Concepedia

A placebo-controlled trial of silymarin in patients with nonalcoholic fatty liver disease.

Seyed Jalal Hashemi, Eskandar Hajiani, Ebrahim Haidari Sardabi

2009 · 64 citations · 23 references

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a spectrum of conditions ranging from simple fatty infiltration of the liver to steatohepatitis, fibrosis, and cirrhosis. Nonalcoholic steatohepatitis (NASH) is histologically characterized by significant

References

23

Nonalcoholic Fatty Liver Disease

Giulio Marchesini, Mara Brizi, Giampaolo Bianchi et al. · Diabetes · 2001 · 2.6K citations · Full text

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

Renata Belfort, Stephen A. Harrison, Kenneth Brown et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Nonalcoholic steatohepatitis: An expanded clinical entity

Bruce R. Bacon, M J Farahvash, Christine G. Janney et al. · Gastroenterology · 1994 · 1.1K citations

, , +8

Ultrasound scanning in the detection of hepatic fibrosis and steatosis.

S.H. Saverymuttu, A.E.A. Joseph, J. D. Maxwell · BMJ · 1986 · 843 citations · Full text

, , +23

Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

Stephen A. Harrison, Sigurd Torgerson, Paul H. Hayashi et al. · The American Journal of Gastroenterology · 2003 · 706 citations